Answers are grounded in this paper and cite their sources.
Nationwide registry analysis demonstrates longer PD duration in female patients, indicating significant sex disparities.
Peritoneal dialysis (PD) duration is limited worldwide by PD-related infections and difficulties in fluid and solute management. Sex-associated differences in PD duration among Japanese patients have not been well characterized. We examined sex-associated differences in clinical characteristics, PD duration, and PD-related outcomes using a nationwide Japanese registry. We retrospectively analyzed annual aggregated data of adult Japanese patients on PD extracted from the Japanese Society for Dialysis Therapy Renal Data Registry (2014–2023; cumulative 74,274 patients). Because the extract contained annual aggregated statistics rather than individual-level data, analyses were descriptive and based on within-year cross-sectional comparisons. We compared male and female patients regarding PD duration, fluid management, solute clearance, and PD-related infections, and performed diabetes-stratified analyses, a descriptive temporal trend analysis, and body-composition–corrected sensitivity analyses for fluid output indices. Female patients consistently had longer mean PD duration than male patients in every year from 2014 to 2023; in 2023, the difference was 4.80 months (95% confidence interval, 3.10 to 6.50), and the 10-year sample size-weighted mean was 28.59 months in male versus 34.73 months in female patients. Female patients also had higher registry-reported total Kt/V (weighted mean, 1.90 vs. 1.76) and a higher total output (urine output + PD ultrafiltration volume) / body weight ratio, calculated as a ratio of annual means (24.0 vs. 21.5 mL/kg/day). The sex difference in PD duration persisted in both diabetic and non-diabetic strata. In this nationwide descriptive analysis, female patients on PD in Japan had longer registry-recorded PD duration and higher registry-reported indices of fluid and solute management than male patients, with differences persisting across diabetes strata. However, because the analyses were based on aggregated registry data with substantial, potentially non-random missingness and without patient-level adjustment, causal inference is not possible, and the findings should be interpreted strictly as registry-level descriptive associations rather than patient-level survival or technique-failure differences.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: